HK1223685A1 - 尿苷飲食添加順應性方法及其用途 - Google Patents

尿苷飲食添加順應性方法及其用途

Info

Publication number
HK1223685A1
HK1223685A1 HK16112021.0A HK16112021A HK1223685A1 HK 1223685 A1 HK1223685 A1 HK 1223685A1 HK 16112021 A HK16112021 A HK 16112021A HK 1223685 A1 HK1223685 A1 HK 1223685A1
Authority
HK
Hong Kong
Prior art keywords
dietary supplementation
compliance methods
uridine
uridine dietary
compliance
Prior art date
Application number
HK16112021.0A
Other languages
English (en)
Inventor
．武特曼
Original Assignee
Massachusetts Inst Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Massachusetts Inst Technology filed Critical Massachusetts Inst Technology
Publication of HK1223685A1 publication Critical patent/HK1223685A1/zh

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/46—NMR spectroscopy
    • G01R33/465—NMR spectroscopy applied to biological material, e.g. in vitro testing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
    • G01R33/485—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy based on chemical shift information [CSI] or spectroscopic imaging, e.g. to acquire the spatial distributions of metabolites

Landscapes

  • Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HK16112021.0A 2007-11-02 2016-10-19 尿苷飲食添加順應性方法及其用途 HK1223685A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US99614607P 2007-11-02 2007-11-02

Publications (1)

Publication Number Publication Date
HK1223685A1 true HK1223685A1 (zh) 2017-08-04

Family

ID=40588272

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16112021.0A HK1223685A1 (zh) 2007-11-02 2016-10-19 尿苷飲食添加順應性方法及其用途

Country Status (6)

Country Link
US (1) US8551452B2 (zh)
EP (1) EP2217075A4 (zh)
CN (2) CN101896119A (zh)
BR (1) BRPI0817387A2 (zh)
HK (1) HK1223685A1 (zh)
WO (1) WO2009059306A1 (zh)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2012125020A1 (en) * 2011-03-14 2012-09-20 N.V. Nutricia Method for treating neurotrauma
WO2015084158A1 (en) * 2013-12-06 2015-06-11 N.V. Nutricia A pyrimidine derivative and a fatty acid source for use in the treatment of constipation
WO2015115885A1 (en) * 2014-01-31 2015-08-06 N.V. Nutricia Method for reducing white matter lesions, white matter hyperintensities (wmh), leukoaraiosis or periventricular white matter disease in elderly
WO2017069613A1 (en) 2015-10-23 2017-04-27 N.V. Nutricia Method for improving recognition and/or working memory in hyperphenylalanimenia and phenylketonuria patients

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4221784A (en) * 1979-04-05 1980-09-09 Massachusetts Institute Of Technology Process and composition for treating disorders by administering lecithin
IT1178044B (it) 1984-10-09 1987-09-03 Polifarma Spa Agente attivo farmaceutico per il trattamento di patologie cerebrali a base di uridina
JP2894610B2 (ja) * 1987-10-28 1999-05-24 プロ−ニューロン，インコーポレーテッド アシル化ウリジンおよびシチジンならびにその使用
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
IT1219667B (it) 1988-06-21 1990-05-24 Polifarma Spa Impiego di uridina nel trattamento farmacologico di disturbi dovuti ad alterato equilibrio dopaminergico
US5141943A (en) * 1990-04-12 1992-08-25 Brown University Research Foundation 5-benzyl barbiturate derivatives
IT1241984B (it) 1990-06-13 1994-02-02 Polifarma Spa Impiego di uridina nel trattamento farmacologico delle complicazioni periferiche del diabete
US6294914B1 (en) * 1993-06-02 2001-09-25 The Board Of Trustees Of The University Of Illinois Method of enhancing an MRI signal
US20050027004A1 (en) * 1993-06-09 2005-02-03 Martek Biosciences Corporation Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
US5567689A (en) * 1993-08-13 1996-10-22 The Uab Research Foundation Methods for increasing uridine levels with L-nucleosides
JPH07215879A (ja) 1994-02-02 1995-08-15 Otsuka Pharmaceut Factory Inc 抗ストレス組成物
DE69527742T2 (de) * 1994-05-06 2002-12-05 Esp Farmaceuticas Centrum Sa Pharmazeutische Zusammensetzung enthaltend Farnextrakt(e) zur Behandlung von neurodegenerativen Krankheiten.
JPH0930976A (ja) 1995-07-17 1997-02-04 Otsuka Pharmaceut Factory Inc 記憶低下改善剤
US5843024A (en) 1996-05-17 1998-12-01 Breonics, Inc. Solution and process for resuscitation and preparation of ischemically damaged tissue
US5962459A (en) * 1996-05-28 1999-10-05 Polifarma S.P.A. Therapeutic active agent for treatment of neuron degenerative diseases
IT1290781B1 (it) 1996-05-28 1998-12-10 Polifarma Spa Agente attivo terapeutico per il trattamento di malattie degenerative neuronali.
US5958896A (en) * 1997-08-08 1999-09-28 The Mclean Hospital Cytidine-containing and cytosine-containing compounds as treatments for stimulant exposure
US5977174A (en) * 1997-11-26 1999-11-02 Neuromedica, Inc. Cholinergic compositions and uses thereof
US6132724A (en) * 1998-04-29 2000-10-17 City Of Hope National Medical Center Allelic polygene diagnosis of reward deficiency syndrome and treatment
US8518882B2 (en) 1998-07-31 2013-08-27 Massachusetts Institute Of Technology Methods and compositions for ameliorating or inhibiting decline in memory or intelligence or improving same
US20060069061A1 (en) * 1998-07-31 2006-03-30 Dick Wurtman Compositions containing uridine and choline, and methods utilizing same
US20050203053A1 (en) * 1999-07-30 2005-09-15 Wurtman Richard J. Uridine administration improves phosphatide synthesis, synaptic transmission and cogntive function
US20070004670A1 (en) * 1998-07-31 2007-01-04 Richard Wurtman Compositions containing citicoline, and methods of use thereof
ATE446097T1 (de) 1998-07-31 2009-11-15 Massachusetts Inst Technology Verwendung von uridin in kombination mit cholin zur behandlung von gedächtnisstörungen
US6472378B2 (en) * 1998-08-31 2002-10-29 Pro-Neuron, Inc. Compositions and methods for treatment of mitochondrial diseases
US6191154B1 (en) * 1998-11-27 2001-02-20 Case Western Reserve University Compositions and methods for the treatment of Alzheimer's disease, central nervous system injury, and inflammatory diseases
EP1171137B1 (en) 1999-02-23 2007-12-26 The Regents of the University of California Use of triacetyluridine for the treatment of mitochondrial disorders
JP2001233776A (ja) 2000-02-25 2001-08-28 Yamasa Shoyu Co Ltd 学習・記憶能低下改善剤およびその用途
US6819952B2 (en) * 2001-03-23 2004-11-16 The Board Of Trustees Of The Leland Stanford Junior University Magnetic resonance spectroscopic imaging method to monitor progression and treatment of neurodegenerative conditions
GB0111282D0 (en) 2001-05-09 2001-06-27 Laxdale Ltd Potentiation of therapeutic effects of fatty acids
US20030114415A1 (en) * 2001-12-14 2003-06-19 Wurtman Richard J. Compositions and methods for treating and preventing memory impairment using citicoline
US20050129710A1 (en) 2003-10-08 2005-06-16 Renshaw Perry F. Methods of treating psychiatric substance abuse, and other disorders using combinations containing omega-3 fatty acids
WO2005122767A1 (en) * 2004-06-10 2005-12-29 Mclean Hospital Corporation Pyrimidines, such as uridine, in treatments for patients with bipolar disorder
KR100645184B1 (ko) * 2004-11-18 2006-11-10 주식회사 엘지화학 열가소성탄성체를 이용한 탈ｐｖｃ바닥재 및 그의 제조방법
WO2006103594A2 (en) * 2005-04-01 2006-10-05 Koninklijke Philips Electronics N.V. A method, a system and a computer program for segmenting a structure in a dataset
EP1888081B1 (en) * 2005-05-23 2016-12-28 Massachusetts Institute of Technology Compositions containing pufa and methods of use thereof
EP1901652B1 (en) * 2005-05-25 2013-07-17 Koninklijke Philips Electronics N.V. Off-magnet patient scan positioning
DK1800675T3 (da) * 2005-12-23 2011-09-05 Nutricia Nv Sammensætninger omfattende polyumættede fedtsyrer, proteiner og mangan og/eller molybdæn og nucleosider/nucleotider til behandling af demens

Also Published As

Publication number Publication date
BRPI0817387A2 (pt) 2015-09-08
EP2217075A1 (en) 2010-08-18
WO2009059306A1 (en) 2009-05-07
CN101896119A (zh) 2010-11-24
US20090117051A1 (en) 2009-05-07
US8551452B2 (en) 2013-10-08
CN105510850A (zh) 2016-04-20
EP2217075A4 (en) 2012-01-25

Similar Documents

Publication Publication Date Title
GB2442571B (en) Spectrum-sensing algorithms and methods
IL205571A0 (en) 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin
ZA200808635B (en) Food supplements and uses thereof
HK1140616A1 (zh) 定時和操作
EP2185692A4 (en) HCO32 AND HCO27 AND RELATED EXAMPLES
IL211042A0 (en) Imidazopyridin-2-one derivatives and uses thereof
ZA200810323B (en) Fkbp-l and uses thereof
ZA201103635B (en) Azaquinolinone derivatives and uses thereof
PL2351001T3 (pl) Symulator ruchu i orientacji
LT2064327T (lt) Dbait ir jų panaudojimas
IL247957A0 (en) Anti-ephrinb2 antibodies and methods of using them
HK1133552A1 (zh) 碳硼烷基卟啉及其用途
IL208771A0 (en) Iminopyridine derivatives and use thereof
GB0721291D0 (en) Methods and compositions
GB0616687D0 (en) Fluid-flow apparatus and arrangements
HK1223685A1 (zh) 尿苷飲食添加順應性方法及其用途
EP2213675A4 (en) PYRIDOOXAZEPINE DERIVATIVE AND USE THEREOF
IL199991A0 (en) Soluble fcgammaria and related methods
GB0719526D0 (en) Compositions and methods
ZA200900960B (en) Arylpiperazine derivatives and uses thereof
IL206951A0 (en) 3-alkyl-piperazine derivatives and uses thereof
GB0707069D0 (en) Methods and uses
EP2274294A4 (en) 5-DIMETHOXY FUMAGILLOL AND ITS DERIVATIVES
GB0610059D0 (en) Uses and methods
GB0518777D0 (en) Products and methods